Home › Funds › Corvex Management › FTRE
Corvex Management position in FTRE
FORTREA HLDGS INC · Health Care
Corvex Management reported holding 2,046,661 shares of FTRE (FORTREA HLDGS INC) in its Q3 2026 13F filing — a position valued at US$40.8M, representing 1.24% of its reported portfolio and ranking #19 among its reported holdings. Corvex Management has disclosed FTRE holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Corvex Management's FTRE position evolved
Corvex Management first disclosed a stake in FTRE in Q3 2024 at 2,220,742 shares (US$44.4M). The position peaked in Q4 2025 at 4,508,531 shares, worth US$77.8M. Across 9 filings, Corvex Management increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,046,661 shares valued at US$40.8M — a reduction of -941,890 shares quarter over quarter.. Notable position changes include a 57% increase in Q4 2024 (shares fell 60% over the following quarter), a 36% trim in Q2 2026 (shares rose 15% over the following quarter), a 32% trim in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 2.22M | $44.41M | New |
| Q4 2024 | 3.48M | $64.92M | Add |
| Q1 2025 | 4.47M | $33.79M | Add |
| Q2 2025 | 4.51M | $22.27M | Add |
| Q3 2025 | 4.51M | $37.96M | Hold |
| Q4 2025 | 4.51M | $77.77M | Hold |
| Q1 2026 | 4.64M | $43.75M | Add |
| Q2 2026 | 2.99M | $52.00M | Reduce |
| Q3 2026 | 2.05M | $40.83M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FTRE and 13F data
FTRE (FORTREA HLDGS INC) is a Health Care company. 34 other funds we track also report a position in FTRE — the largest reported positions include Sessa Capital IM, L.P. (US$91.6M), Park West Asset Management LLC (US$39.7M), Eagle Health Investments LP (US$23.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FTRE
- Sessa Capital IM, L.P. 4.59M sh · $91.64M · Q3 2026
- Park West Asset Management LLC 1.99M sh · $39.68M · Q3 2026
- Eagle Health Investments LP 1.18M sh · $23.57M · Q3 2026
- Penn Capital Management Company, LLC 1.14M sh · $22.79M · Q3 2026
- BECK MACK & OLIVER LLC 967.30K sh · $19.30M · Q3 2026
More on Corvex Management
FAQ
How long has Corvex Management held FTRE?
Corvex Management has disclosed FTRE holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Corvex Management's current position in FTRE?
As of Q3 2026, Corvex Management holds 2.05M shares of FTRE (FORTREA HLDGS INC), valued at $40.83M, representing 1.24% of its reported portfolio and ranking #19.
Has Corvex Management been buying or selling FTRE?
In the latest 13F filing (Q3 2026), Corvex Management reduced its position in FTRE. The position peaked in Q4 2025 at 4.51M shares.
Which other funds hold FTRE?
Other major institutional holders of FTRE include Sessa Capital IM, L.P., Park West Asset Management LLC, Eagle Health Investments LP, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.